PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Center for Genome Technology and Biomolecular Engineering, Columbia University, New York, New York, USA.\', \'Department of Chemical Engineering, Columbia University, New York, NY, USA.\', \'Department of Molecular Pharmacology and Therapeutics, Columbia University, New York, NY, USA.\', \'Department of Chemistry, Columbia University, New York, NY, USA.\', \'Department of Biochemistry, University of Wisconsin-Madison, Madison, Wisconsin, USA.\', \'Institute of Molecular Virology, University of Wisconsin-Madison, Madison, Wisconsin, USA.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1002/prp2.674
?:hasPublicationType
?:journal
  • Pharmacology research & perspectives
is ?:pmid of
?:pmid
?:pmid
  • 33124786
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Nucleotide analogues as inhibitors of SARS-CoV Polymerase.
?:type
?:year
  • 2020

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/33124786>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/33124786>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all